Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis.

ABSTRACT: Breast cancer survival rates have markedly improved. Consequently, survivorship issues have received increased attention. One common sequel of treatment is chemotherapy-induced cognitive impairment (CICI). CICI causes a range of impairments that can have a significant negative impact on quality of life. Knowledge of the prevalence of this condition is required to inform survivorship plans, and ensure adequate resource allocation and support is available for sufferers, hence a systematic review of prevalence data was performed. Medline, Scopus, CINAHL and PSYCHInfo were searched for eligible studies which included prevalence data on CICI, as ascertained though the use of self-report, or neuropsychological tests. Methodological quality of included studies was assessed. Findings were synthesi

SUBMITTER: Whittaker AL 

PROVIDER: S-EPMC8826852 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature